Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04925986
Title Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sarah Goldberg
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST